Global Low Molecular Weight Heparin API Supply, Demand and Key Producers, 2024-2030
Page: 125
Published Date: 11 Oct 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.
The global Low Molecular Weight Heparin API market size is expected to reach $ 1580 million by 2030, rising at a market growth of 11.9% CAGR during the forecast period (2024-2030).
The Low Molecular Weight Heparin (LMWH) API market plays a crucial role in the global pharmaceutical industry due to the widespread use of LMWHs in the prevention and treatment of blood clot-related disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH APIs are preferred in clinical settings for their favorable pharmacological properties, including better bioavailability, longer half-life, and reduced risk of side effects compared to unfractionated heparin. The increasing prevalence of cardiovascular diseases and venous thromboembolism, aging populations, and a rise in surgical procedures worldwide have significantly driven demand for LMWH-based therapies.
The global market for Low Molecular Weight Heparin API was estimated to be worth US$ 0.78 billion in 2024 and is forecast to a readjusted size of US$ 1.56 billion by 2030 with a CAGR of 12.21% during the forecast period 2024-2030.
The North American and European markets lead in demand due to a high prevalence of thrombosis-related conditions and advanced healthcare infrastructure. Asia-Pacific is emerging as a growth market, driven by increased healthcare spending and the rise of generics. North American market for Low Molecular Weight Heparin API was valued at $ 294.19 million in 2023 and will reach $ 523.34 million by 2030, at a CAGR of 12.54% during the forecast period of 2024 through 2030. Asia-Pacific market for Low Molecular Weight Heparin API was valued at $ 293.62 million in 2023 and will reach $ 496.95 million by 2030, at a CAGR of 12.81% during the forecast period of 2024 through 2030. Europe market for Low Molecular Weight Heparin API was valued at $ 307.93 million in 2023 and will reach $ 521.29 million by 2030, at a CAGR of 11.45% during the forecast period of 2024 through 2030.
Low Molecular Weight Heparin API segment market, the Enoxaparin Sodium holds an important share, and it is expected to reach a value of US$ 1,258.82 million by 2030, at a CAGR of 12.46% during 2024 and 2030.
The global key companies of Low Molecular Weight Heparin API include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, and Qingdao Jiulong Biopharmaceutical, etc. In 2023, the global five largest players hold a share approximately 72.91% in terms of revenue.
This report studies the global Low Molecular Weight Heparin API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Low Molecular Weight Heparin API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Low Molecular Weight Heparin API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Low Molecular Weight Heparin API total production and demand, 2019-2030, (Billion Units)
Global Low Molecular Weight Heparin API total production value, 2019-2030, (USD Million)
Global Low Molecular Weight Heparin API production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Billion Units), (based on production site)
Global Low Molecular Weight Heparin API consumption by region & country, CAGR, 2019-2030 & (Billion Units)
U.S. VS China: Low Molecular Weight Heparin API domestic production, consumption, key domestic manufacturers and share
Global Low Molecular Weight Heparin API production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Billion Units)
Global Low Molecular Weight Heparin API production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Billion Units)
Global Low Molecular Weight Heparin API production by Application, production, value, CAGR, 2019-2030, (USD Million) & (Billion Units)
This report profiles key players in the global Low Molecular Weight Heparin API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan, Hubei Enoray Biopharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Low Molecular Weight Heparin API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Billion Units) and average price (US$/Billion Untis) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Low Molecular Weight Heparin API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Low Molecular Weight Heparin API Market, Segmentation by Type:
Low Molecular Weight Heparin Sodium
Low Molecular Weight Heparin Calcium
Global Low Molecular Weight Heparin API Market, Segmentation by Application:
Enoxaparin Sodium
Nadroparin Calcium
Dalteparin Sodium
Tinzaparin Sodium
Parnaparin Sodium
Companies Profiled:
Yantai Dongcheng Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Nanjing King-friend
Changzhou Qianhong Biopharma
Qingdao Jiulong Biopharmaceutical
Dongying Tiandong Pharmaceutical
Yino Pharma
Opocrin
Hebei Changshan
Hubei Enoray Biopharmaceutical
Nanjing Nanda Pharmaceutical
Cisen Pharmaceutical
Key Questions Answered:
1. How big is the global Low Molecular Weight Heparin API market?
2. What is the demand of the global Low Molecular Weight Heparin API market?
3. What is the year over year growth of the global Low Molecular Weight Heparin API market?
4. What is the production and production value of the global Low Molecular Weight Heparin API market?
5. Who are the key producers in the global Low Molecular Weight Heparin API market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Low Molecular Weight Heparin API Introduction
1.2 World Low Molecular Weight Heparin API Supply & Forecast
1.2.1 World Low Molecular Weight Heparin API Production Value (2019 & 2023 & 2030)
1.2.2 World Low Molecular Weight Heparin API Production (2019-2030)
1.2.3 World Low Molecular Weight Heparin API Pricing Trends (2019-2030)
1.3 World Low Molecular Weight Heparin API Production by Region (Based on Production Site)
1.3.1 World Low Molecular Weight Heparin API Production Value by Region (2019-2030)
1.3.2 World Low Molecular Weight Heparin API Production by Region (2019-2030)
1.3.3 World Low Molecular Weight Heparin API Average Price by Region (2019-2030)
1.3.4 North America Low Molecular Weight Heparin API Production (2019-2030)
1.3.5 Europe Low Molecular Weight Heparin API Production (2019-2030)
1.3.6 China Low Molecular Weight Heparin API Production (2019-2030)
1.3.7 Japan Low Molecular Weight Heparin API Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Low Molecular Weight Heparin API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Low Molecular Weight Heparin API Major Market Trends
2.1 World Low Molecular Weight Heparin API Demand (2019-2030)
2.2 World Low Molecular Weight Heparin API Consumption by Region
2.2.1 World Low Molecular Weight Heparin API Consumption by Region (2019-2024)
2.2.2 World Low Molecular Weight Heparin API Consumption Forecast by Region (2025-2030)
2.3 United States Low Molecular Weight Heparin API Consumption (2019-2030)
2.4 China Low Molecular Weight Heparin API Consumption (2019-2030)
2.5 Europe Low Molecular Weight Heparin API Consumption (2019-2030)
2.6 Japan Low Molecular Weight Heparin API Consumption (2019-2030)
2.7 South Korea Low Molecular Weight Heparin API Consumption (2019-2030)
2.8 ASEAN Low Molecular Weight Heparin API Consumption (2019-2030)
2.9 India Low Molecular Weight Heparin API Consumption (2019-2030)
3.1 World Low Molecular Weight Heparin API Production Value by Manufacturer (2019-2024)
3.2 World Low Molecular Weight Heparin API Production by Manufacturer (2019-2024)
3.3 World Low Molecular Weight Heparin API Average Price by Manufacturer (2019-2024)
3.4 Low Molecular Weight Heparin API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Low Molecular Weight Heparin API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Low Molecular Weight Heparin API in 2023
3.5.3 Global Concentration Ratios (CR8) for Low Molecular Weight Heparin API in 2023
3.6 Low Molecular Weight Heparin API Market: Overall Company Footprint Analysis
3.6.1 Low Molecular Weight Heparin API Market: Region Footprint
3.6.2 Low Molecular Weight Heparin API Market: Company Product Type Footprint
3.6.3 Low Molecular Weight Heparin API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Low Molecular Weight Heparin API Production Value Comparison
4.1.1 United States VS China: Low Molecular Weight Heparin API Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Low Molecular Weight Heparin API Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Low Molecular Weight Heparin API Production Comparison
4.2.1 United States VS China: Low Molecular Weight Heparin API Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Low Molecular Weight Heparin API Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Low Molecular Weight Heparin API Consumption Comparison
4.3.1 United States VS China: Low Molecular Weight Heparin API Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Low Molecular Weight Heparin API Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Low Molecular Weight Heparin API Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Low Molecular Weight Heparin API Production Value (2019-2024)
4.4.3 United States Based Manufacturers Low Molecular Weight Heparin API Production (2019-2024)
4.5 China Based Low Molecular Weight Heparin API Manufacturers and Market Share
4.5.1 China Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Low Molecular Weight Heparin API Production Value (2019-2024)
4.5.3 China Based Manufacturers Low Molecular Weight Heparin API Production (2019-2024)
4.6 Rest of World Based Low Molecular Weight Heparin API Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Low Molecular Weight Heparin API Production (2019-2024)
5.1 World Low Molecular Weight Heparin API Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Low Molecular Weight Heparin Sodium
5.2.2 Low Molecular Weight Heparin Calcium
5.3 Market Segment by Type
5.3.1 World Low Molecular Weight Heparin API Production by Type (2019-2030)
5.3.2 World Low Molecular Weight Heparin API Production Value by Type (2019-2030)
5.3.3 World Low Molecular Weight Heparin API Average Price by Type (2019-2030)
6.1 World Low Molecular Weight Heparin API Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Enoxaparin Sodium
6.2.2 Nadroparin Calcium
6.2.3 Dalteparin Sodium
6.2.4 Tinzaparin Sodium
6.2.5 Parnaparin Sodium
6.3 Market Segment by Application
6.3.1 World Low Molecular Weight Heparin API Production by Application (2019-2030)
6.3.2 World Low Molecular Weight Heparin API Production Value by Application (2019-2030)
6.3.3 World Low Molecular Weight Heparin API Average Price by Application (2019-2030)
7.1 Yantai Dongcheng Pharmaceutical
7.1.1 Yantai Dongcheng Pharmaceutical Details
7.1.2 Yantai Dongcheng Pharmaceutical Major Business
7.1.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product and Services
7.1.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
7.1.6 Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
7.2 Shenzhen Hepalink Pharmaceutical
7.2.1 Shenzhen Hepalink Pharmaceutical Details
7.2.2 Shenzhen Hepalink Pharmaceutical Major Business
7.2.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product and Services
7.2.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
7.2.6 Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
7.3 Nanjing King-friend
7.3.1 Nanjing King-friend Details
7.3.2 Nanjing King-friend Major Business
7.3.3 Nanjing King-friend Low Molecular Weight Heparin API Product and Services
7.3.4 Nanjing King-friend Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Nanjing King-friend Recent Developments/Updates
7.3.6 Nanjing King-friend Competitive Strengths & Weaknesses
7.4 Changzhou Qianhong Biopharma
7.4.1 Changzhou Qianhong Biopharma Details
7.4.2 Changzhou Qianhong Biopharma Major Business
7.4.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product and Services
7.4.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Changzhou Qianhong Biopharma Recent Developments/Updates
7.4.6 Changzhou Qianhong Biopharma Competitive Strengths & Weaknesses
7.5 Qingdao Jiulong Biopharmaceutical
7.5.1 Qingdao Jiulong Biopharmaceutical Details
7.5.2 Qingdao Jiulong Biopharmaceutical Major Business
7.5.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product and Services
7.5.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
7.5.6 Qingdao Jiulong Biopharmaceutical Competitive Strengths & Weaknesses
7.6 Dongying Tiandong Pharmaceutical
7.6.1 Dongying Tiandong Pharmaceutical Details
7.6.2 Dongying Tiandong Pharmaceutical Major Business
7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product and Services
7.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
7.6.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
7.7 Yino Pharma
7.7.1 Yino Pharma Details
7.7.2 Yino Pharma Major Business
7.7.3 Yino Pharma Low Molecular Weight Heparin API Product and Services
7.7.4 Yino Pharma Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Yino Pharma Recent Developments/Updates
7.7.6 Yino Pharma Competitive Strengths & Weaknesses
7.8 Opocrin
7.8.1 Opocrin Details
7.8.2 Opocrin Major Business
7.8.3 Opocrin Low Molecular Weight Heparin API Product and Services
7.8.4 Opocrin Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Opocrin Recent Developments/Updates
7.8.6 Opocrin Competitive Strengths & Weaknesses
7.9 Hebei Changshan
7.9.1 Hebei Changshan Details
7.9.2 Hebei Changshan Major Business
7.9.3 Hebei Changshan Low Molecular Weight Heparin API Product and Services
7.9.4 Hebei Changshan Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hebei Changshan Recent Developments/Updates
7.9.6 Hebei Changshan Competitive Strengths & Weaknesses
7.10 Hubei Enoray Biopharmaceutical
7.10.1 Hubei Enoray Biopharmaceutical Details
7.10.2 Hubei Enoray Biopharmaceutical Major Business
7.10.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product and Services
7.10.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
7.10.6 Hubei Enoray Biopharmaceutical Competitive Strengths & Weaknesses
7.11 Nanjing Nanda Pharmaceutical
7.11.1 Nanjing Nanda Pharmaceutical Details
7.11.2 Nanjing Nanda Pharmaceutical Major Business
7.11.3 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product and Services
7.11.4 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Nanjing Nanda Pharmaceutical Recent Developments/Updates
7.11.6 Nanjing Nanda Pharmaceutical Competitive Strengths & Weaknesses
7.12 Cisen Pharmaceutical
7.12.1 Cisen Pharmaceutical Details
7.12.2 Cisen Pharmaceutical Major Business
7.12.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Product and Services
7.12.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Cisen Pharmaceutical Recent Developments/Updates
7.12.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses
8.1 Low Molecular Weight Heparin API Industry Chain
8.2 Low Molecular Weight Heparin API Upstream Analysis
8.2.1 Low Molecular Weight Heparin API Core Raw Materials
8.2.2 Main Manufacturers of Low Molecular Weight Heparin API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Low Molecular Weight Heparin API Production Mode
8.6 Low Molecular Weight Heparin API Procurement Model
8.7 Low Molecular Weight Heparin API Industry Sales Model and Sales Channels
8.7.1 Low Molecular Weight Heparin API Sales Model
8.7.2 Low Molecular Weight Heparin API Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Low Molecular Weight Heparin API Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Low Molecular Weight Heparin API Production Value by Region (2019-2024) & (USD Million)
Table 3. World Low Molecular Weight Heparin API Production Value by Region (2025-2030) & (USD Million)
Table 4. World Low Molecular Weight Heparin API Production Value Market Share by Region (2019-2024)
Table 5. World Low Molecular Weight Heparin API Production Value Market Share by Region (2025-2030)
Table 6. World Low Molecular Weight Heparin API Production by Region (2019-2024) & (Billion Units)
Table 7. World Low Molecular Weight Heparin API Production by Region (2025-2030) & (Billion Units)
Table 8. World Low Molecular Weight Heparin API Production Market Share by Region (2019-2024)
Table 9. World Low Molecular Weight Heparin API Production Market Share by Region (2025-2030)
Table 10. World Low Molecular Weight Heparin API Average Price by Region (2019-2024) & (US$/Billion Untis)
Table 11. World Low Molecular Weight Heparin API Average Price by Region (2025-2030) & (US$/Billion Untis)
Table 12. Low Molecular Weight Heparin API Major Market Trends
Table 13. World Low Molecular Weight Heparin API Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Billion Units)
Table 14. World Low Molecular Weight Heparin API Consumption by Region (2019-2024) & (Billion Units)
Table 15. World Low Molecular Weight Heparin API Consumption Forecast by Region (2025-2030) & (Billion Units)
Table 16. World Low Molecular Weight Heparin API Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Low Molecular Weight Heparin API Producers in 2023
Table 18. World Low Molecular Weight Heparin API Production by Manufacturer (2019-2024) & (Billion Units)
Table 19. Production Market Share of Key Low Molecular Weight Heparin API Producers in 2023
Table 20. World Low Molecular Weight Heparin API Average Price by Manufacturer (2019-2024) & (US$/Billion Untis)
Table 21. Global Low Molecular Weight Heparin API Company Evaluation Quadrant
Table 22. World Low Molecular Weight Heparin API Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Low Molecular Weight Heparin API Production Site of Key Manufacturer
Table 24. Low Molecular Weight Heparin API Market: Company Product Type Footprint
Table 25. Low Molecular Weight Heparin API Market: Company Product Application Footprint
Table 26. Low Molecular Weight Heparin API Competitive Factors
Table 27. Low Molecular Weight Heparin API New Entrant and Capacity Expansion Plans
Table 28. Low Molecular Weight Heparin API Mergers & Acquisitions Activity
Table 29. United States VS China Low Molecular Weight Heparin API Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Low Molecular Weight Heparin API Production Comparison, (2019 & 2023 & 2030) & (Billion Units)
Table 31. United States VS China Low Molecular Weight Heparin API Consumption Comparison, (2019 & 2023 & 2030) & (Billion Units)
Table 32. United States Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Low Molecular Weight Heparin API Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Low Molecular Weight Heparin API Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Low Molecular Weight Heparin API Production (2019-2024) & (Billion Units)
Table 36. United States Based Manufacturers Low Molecular Weight Heparin API Production Market Share (2019-2024)
Table 37. China Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Low Molecular Weight Heparin API Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Low Molecular Weight Heparin API Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Low Molecular Weight Heparin API Production, (2019-2024) & (Billion Units)
Table 41. China Based Manufacturers Low Molecular Weight Heparin API Production Market Share (2019-2024)
Table 42. Rest of World Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Low Molecular Weight Heparin API Production, (2019-2024) & (Billion Units)
Table 46. Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Market Share (2019-2024)
Table 47. World Low Molecular Weight Heparin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Low Molecular Weight Heparin API Production by Type (2019-2024) & (Billion Units)
Table 49. World Low Molecular Weight Heparin API Production by Type (2025-2030) & (Billion Units)
Table 50. World Low Molecular Weight Heparin API Production Value by Type (2019-2024) & (USD Million)
Table 51. World Low Molecular Weight Heparin API Production Value by Type (2025-2030) & (USD Million)
Table 52. World Low Molecular Weight Heparin API Average Price by Type (2019-2024) & (US$/Billion Untis)
Table 53. World Low Molecular Weight Heparin API Average Price by Type (2025-2030) & (US$/Billion Untis)
Table 54. World Low Molecular Weight Heparin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Low Molecular Weight Heparin API Production by Application (2019-2024) & (Billion Units)
Table 56. World Low Molecular Weight Heparin API Production by Application (2025-2030) & (Billion Units)
Table 57. World Low Molecular Weight Heparin API Production Value by Application (2019-2024) & (USD Million)
Table 58. World Low Molecular Weight Heparin API Production Value by Application (2025-2030) & (USD Million)
Table 59. World Low Molecular Weight Heparin API Average Price by Application (2019-2024) & (US$/Billion Untis)
Table 60. World Low Molecular Weight Heparin API Average Price by Application (2025-2030) & (US$/Billion Untis)
Table 61. Yantai Dongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Yantai Dongcheng Pharmaceutical Major Business
Table 63. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product and Services
Table 64. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 66. Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Shenzhen Hepalink Pharmaceutical Major Business
Table 69. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product and Services
Table 70. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 72. Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Nanjing King-friend Basic Information, Manufacturing Base and Competitors
Table 74. Nanjing King-friend Major Business
Table 75. Nanjing King-friend Low Molecular Weight Heparin API Product and Services
Table 76. Nanjing King-friend Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Nanjing King-friend Recent Developments/Updates
Table 78. Nanjing King-friend Competitive Strengths & Weaknesses
Table 79. Changzhou Qianhong Biopharma Basic Information, Manufacturing Base and Competitors
Table 80. Changzhou Qianhong Biopharma Major Business
Table 81. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product and Services
Table 82. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 84. Changzhou Qianhong Biopharma Competitive Strengths & Weaknesses
Table 85. Qingdao Jiulong Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Qingdao Jiulong Biopharmaceutical Major Business
Table 87. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product and Services
Table 88. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 90. Qingdao Jiulong Biopharmaceutical Competitive Strengths & Weaknesses
Table 91. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Dongying Tiandong Pharmaceutical Major Business
Table 93. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product and Services
Table 94. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 96. Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Yino Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Yino Pharma Major Business
Table 99. Yino Pharma Low Molecular Weight Heparin API Product and Services
Table 100. Yino Pharma Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Yino Pharma Recent Developments/Updates
Table 102. Yino Pharma Competitive Strengths & Weaknesses
Table 103. Opocrin Basic Information, Manufacturing Base and Competitors
Table 104. Opocrin Major Business
Table 105. Opocrin Low Molecular Weight Heparin API Product and Services
Table 106. Opocrin Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Opocrin Recent Developments/Updates
Table 108. Opocrin Competitive Strengths & Weaknesses
Table 109. Hebei Changshan Basic Information, Manufacturing Base and Competitors
Table 110. Hebei Changshan Major Business
Table 111. Hebei Changshan Low Molecular Weight Heparin API Product and Services
Table 112. Hebei Changshan Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hebei Changshan Recent Developments/Updates
Table 114. Hebei Changshan Competitive Strengths & Weaknesses
Table 115. Hubei Enoray Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Hubei Enoray Biopharmaceutical Major Business
Table 117. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product and Services
Table 118. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 120. Hubei Enoray Biopharmaceutical Competitive Strengths & Weaknesses
Table 121. Nanjing Nanda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Nanjing Nanda Pharmaceutical Major Business
Table 123. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product and Services
Table 124. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Nanjing Nanda Pharmaceutical Recent Developments/Updates
Table 126. Nanjing Nanda Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Cisen Pharmaceutical Major Business
Table 129. Cisen Pharmaceutical Low Molecular Weight Heparin API Product and Services
Table 130. Cisen Pharmaceutical Low Molecular Weight Heparin API Production (Billion Units), Price (US$/Billion Untis), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Cisen Pharmaceutical Recent Developments/Updates
Table 132. Cisen Pharmaceutical Competitive Strengths & Weaknesses
Table 133. Global Key Players of Low Molecular Weight Heparin API Upstream (Raw Materials)
Table 134. Global Low Molecular Weight Heparin API Typical Customers
Table 135. Low Molecular Weight Heparin API Typical Distributors
List of Figures
Figure 1. Low Molecular Weight Heparin API Picture
Figure 2. World Low Molecular Weight Heparin API Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Low Molecular Weight Heparin API Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Low Molecular Weight Heparin API Production (2019-2030) & (Billion Units)
Figure 5. World Low Molecular Weight Heparin API Average Price (2019-2030) & (US$/Billion Untis)
Figure 6. World Low Molecular Weight Heparin API Production Value Market Share by Region (2019-2030)
Figure 7. World Low Molecular Weight Heparin API Production Market Share by Region (2019-2030)
Figure 8. North America Low Molecular Weight Heparin API Production (2019-2030) & (Billion Units)
Figure 9. Europe Low Molecular Weight Heparin API Production (2019-2030) & (Billion Units)
Figure 10. China Low Molecular Weight Heparin API Production (2019-2030) & (Billion Units)
Figure 11. Japan Low Molecular Weight Heparin API Production (2019-2030) & (Billion Units)
Figure 12. Low Molecular Weight Heparin API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 15. World Low Molecular Weight Heparin API Consumption Market Share by Region (2019-2030)
Figure 16. United States Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 17. China Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 18. Europe Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 19. Japan Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 20. South Korea Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 21. ASEAN Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 22. India Low Molecular Weight Heparin API Consumption (2019-2030) & (Billion Units)
Figure 23. Producer Shipments of Low Molecular Weight Heparin API by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Low Molecular Weight Heparin API Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Low Molecular Weight Heparin API Markets in 2023
Figure 26. United States VS China: Low Molecular Weight Heparin API Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Low Molecular Weight Heparin API Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Low Molecular Weight Heparin API Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Low Molecular Weight Heparin API Production Market Share 2023
Figure 30. China Based Manufacturers Low Molecular Weight Heparin API Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Market Share 2023
Figure 32. World Low Molecular Weight Heparin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Low Molecular Weight Heparin API Production Value Market Share by Type in 2023
Figure 34. Low Molecular Weight Heparin Sodium
Figure 35. Low Molecular Weight Heparin Calcium
Figure 36. World Low Molecular Weight Heparin API Production Market Share by Type (2019-2030)
Figure 37. World Low Molecular Weight Heparin API Production Value Market Share by Type (2019-2030)
Figure 38. World Low Molecular Weight Heparin API Average Price by Type (2019-2030) & (US$/Billion Untis)
Figure 39. World Low Molecular Weight Heparin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Low Molecular Weight Heparin API Production Value Market Share by Application in 2023
Figure 41. Enoxaparin Sodium
Figure 42. Nadroparin Calcium
Figure 43. Dalteparin Sodium
Figure 44. Tinzaparin Sodium
Figure 45. Parnaparin Sodium
Figure 46. World Low Molecular Weight Heparin API Production Market Share by Application (2019-2030)
Figure 47. World Low Molecular Weight Heparin API Production Value Market Share by Application (2019-2030)
Figure 48. World Low Molecular Weight Heparin API Average Price by Application (2019-2030) & (US$/Billion Untis)
Figure 49. Low Molecular Weight Heparin API Industry Chain
Figure 50. Low Molecular Weight Heparin API Procurement Model
Figure 51. Low Molecular Weight Heparin API Sales Model
Figure 52. Low Molecular Weight Heparin API Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Yantai Dongcheng Pharmaceutical Shenzhen Hepalink Pharmaceutical Nanjing King-friend Changzhou Qianhong Biopharma Qingdao Jiulong Biopharmaceutical Dongying Tiandong Pharmaceutical Yino Pharma Opocrin Hebei Changshan Hubei Enoray Biopharmaceutical Nanjing Nanda Pharmaceutical Cisen Pharmaceutical
Related Reports
02 Sep 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
